Navigation Links
Use of BRET2 luminescence cell-based assays with LEADseeker Multimodality Imaging System

Key words: luminescence • BRET2 • LEADseeker • DeepBlueC• cell-based assays

Competitive pressure is forcing organizations to continually increase screening throughput. Yet accuracy and sensitivity remain vital concerns, particularly for common screens such as luminescence cell-based assays. LEADseeker™ Multimodality Imaging System was developed to meet these demands by combining excellent detection with the ability to image whole plates in less than one minute.

This application note describes the use of luminescence emissions filters, which were defined and characterized using the BRET2™ Demonstration Assay Kit. The data demonstrate that BRET2 cell-based assays perform well in conjunction with the chemiluminescent readout of LEADseeker Multimodality Imaging System. Together, the filters, demonstration kit, and assay system support organizations looking to add high and ultra-high throughput luminescence cell based assays to their screening programs.

Products used

LEADseeker Multimodality Imaging System 18-1140-71

Luminescence filter configuration for Bret2 consists of: 11-0013-49

Emission filter (Luciferin donor) 470 nm, bp 50 nm

Emission filter (YFP acceptor) 535 nm, bp 45 nm

Other materials required
BRET2 Demonstration Assay Kit (PerkinElmer)

DeepBlueC™ (PerkinElmer)

384-well plates (non-treated, non-sterile, polystyrene, white)

1. Reagent preparation
1.1 Prepare reagents as recommended by the kit manufacturer. Reagents, cell extracts (three vials) and buffer (four vials) should be thawed on ice.

1.2 Preparation of DeepBlueC

1.2.1 Add 25 µl ethanol to the DeepBlueC vial (final concentration = 1 mM).

1.2.2 Prepare a 100-fold dilution by adding 1.98 ml of buffer to 20 µl of the solution prepared in 1.2.1 (final concentration = 10 µM).

1.2.3 Place the solution on ice, protected from light.

2. Assay procedure
(Note: The assay was set up in triplicate and both 10 µl and 2 µl cell-extract assays were performed in the same microplate.)
2.1 Add 15 µl BRET2 buffer to wells A1–A3, B1–B3, and C1–C3.

2.2 Add 23 µl BRET2 buffer to wells A4–A6, B4–B6, and C4–C6.

2.3 Add 25 µl BRET2 buffer to wells D1–D3.

2.4 Dispense 10 µl of each cell extract as follows:

2.4.1 A1–A3: clear cap (non-transfected cells)

2.4.2 B1–B3: blue cap [9Rluc(h) + GFP2 transfected cells -negative BRET control]

2.4.3 C1–C3: green cap [GFP2 - Rluc(h) fusion transfected cells - positive BRET control]

2.5 Dispense 2 µl of each cell extract as follows:

2.5.1 A4–A6: clear cap (non-transfected cells)

2.5.2 B4–B6: blue cap [9Rluc(h) + GFP2 transfected cells -negative BRET control]

2.5.3 C4–C6: green cap [GFP2 - Rluc(h) fusion transfected cells - positive BRET control]

2.6 Dispense 25 µl 10 µM DeepBlueC (see Reagent Preparation Protocol, above) to all wells.

2.7 Image on LEADseeker Multimodality Imaging System for 60 s (within 60 min following dispensing).

The BRET2 demonstration assay uses the luminescence emission signal from the donor and the luminescence energy transfer signal from the acceptor to generate the two sets of data used for the final analysis. The filters developed for the system are configured for donor emission at 470 nm and 535 nm for acceptor emission.

Table 1 shows the raw signal data generated on the LEADseeker Multimodality Imaging System for the donor and acceptor channels. Signal to noise was calculated using the following equation:

S:N values for all conditions in both assay volumes was < 10:1 (comparable with pack leaflet data), indicating that the signals generated were sufficient for final data analysis.

In the final data analysis, we ratioed the data obtained from the two channels of the raw signal analysis experiment and compared the ratios for the positive and negative control cell extracts (Fig 1).

back to top


Page: All 1 2 3

Related biology technology :

1. Performance of the AMARA HitHunter Chemiluminescence Kinase Assay with the LEADseeker Multimodality Imaging System
2. Photoluminescence Spectroscopy of Quantum Dots, monitored by the Spex FluoroMax
3. Time gated separation of lanthanide luminescence
4. A highly sensitive ATP-luminescence assay using VICTOR2 with the dispenser option
5. LiquiChip Kits for bead-based cytokine and kinase assays
6. Bio-Plex Cytokine Immunoassays and ELISA: Comparison of Two Methodologies in Testing Samples From Asthmatic and Healthy Children, Rev A
7. Principles of Curve Fitting for Multiplex Sandwich Immunoassays, Rev B
8. Is Z factor the best assessment for the quality of cellular assays delivering higher content?
9. The measurement of DNA condensation and mitochondrial changes during apoptosis and necrosis in cell based assays
10. Analysis of in vitro micronucleus assays using the IN Cell Analyzer 3000 Micronuclei Formation Analysis Module
11. Mix-and-Read, Bead- and Cell-Based Immunoassays Using the FMAT 8100 HTS System
Post Your Comments:

(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... CITY , Nov. 24, 2015 /PRNewswire/ - Aeterna ... request of IIROC on behalf of the Toronto Stock ... news release there are no corporate developments that would ... --> --> About ... . --> Aeterna Zentaris is ...
(Date:11/24/2015)... ... ... This fall, global software solutions leader SAP and AdVenture Capital brought together ... their BIG ideas to improve health and wellness in their schools. , Now, the ... title of SAP's Teen Innovator, an all-expenses paid trip to Super Bowl 50, and ...
(Date:11/24/2015)... New York , November 24, 2015 ... to a recent market research report released by Transparency ... projected to expand at a CAGR of 17.5% during ... "Non-invasive Prenatal Testing Market - Global Industry Analysis, Size, ... estimates the global non-invasive prenatal testing market to reach ...
Breaking Biology Technology:
(Date:10/27/2015)... 27, 2015 In the present market scenario, ... for various industry verticals such as banking, healthcare, defense, ... growing demand for secure & simplified access control and ... as hacking of bank accounts, misuse of users, , ... as PC,s, laptops, and smartphones are expected to provide ...
(Date:10/26/2015)... LAS VEGAS , Oct. 26, 2015 ... an innovator in modern authentication and a founding member ... launch of its latest version of the Nok Nok™ ... to use standards-based authentication that supports existing and emerging ... Suite is ideal for organizations deploying customer-facing applications that ...
(Date:10/22/2015)... Inc. (NASDAQ: AWRE ), a leading supplier of biometrics software ... September 30, 2015.  --> --> ... a decrease of 33% compared to $6.0 million in the same ... was $2.2 million, or $0.10 per diluted share, which compared to ... a year ago.  --> --> ...
Breaking Biology News(10 mins):